IndraLab

Statements

Prodrug inhibits IKBKB. 1 / 1

| 1

reach

"IMD-1041 is a prodrug of IMD-0354 that was developed by the Institute of Medicinal Molecular Design and specifically inhibits IKKb in in-vivo [8] and in-vitro experiments [9] ."

21072674

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Prodrug inhibits IKBKB. 1 / 1

INDRA sources:

Databases

Reading